Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Dianthus Therapeutics (DNTH) Return on Capital Employed (2018 - 2025)

Historic Return on Capital Employed for Dianthus Therapeutics (DNTH) over the last 7 years, with Q3 2025 value amounting to 0.33%.

  • Dianthus Therapeutics' Return on Capital Employed fell 900.0% to 0.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.33%, marking a year-over-year decrease of 900.0%. This contributed to the annual value of 0.39% for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Dianthus Therapeutics' Return on Capital Employed stood at 0.33%, which was down 900.0% from 0.41% recorded in Q2 2025.
  • Dianthus Therapeutics' 5-year Return on Capital Employed high stood at 0.19% for Q2 2024, and its period low was 0.58% during Q1 2023.
  • Moreover, its 4-year median value for Return on Capital Employed was 0.34% (2025), whereas its average is 0.36%.
  • In the last 5 years, Dianthus Therapeutics' Return on Capital Employed soared by 3700bps in 2024 and then plummeted by -2200bps in 2025.
  • Quarter analysis of 4 years shows Dianthus Therapeutics' Return on Capital Employed stood at 0.5% in 2022, then skyrocketed by 45bps to 0.27% in 2023, then dropped by -8bps to 0.29% in 2024, then fell by -11bps to 0.33% in 2025.
  • Its last three reported values are 0.33% in Q3 2025, 0.41% for Q2 2025, and 0.34% during Q1 2025.